Somatostatin
You don't need to be Editor-In-Chief to add or edit content to WikiDoc. You can begin to add to or edit text on this WikiDoc page by clicking on the edit button at the top of this page. Next enter or edit the information that you would like to appear here. Once you are done editing, scroll down and click the Save page button at the bottom of the page.
Overview
| | |
| Somatostatin
| |
| Identifiers | |
| Symbol | SST |
| Entrez | 6750 |
| HUGO | 11329 |
| OMIM | 182450 |
| RefSeq | NM_001048 |
| UniProt | P61278 |
| Other data | |
| Locus | Chr. 3 q28 |
|
WikiDoc Resources for Somatostatin | |
|
Articles | |
|---|---|
|
Most recent articles on Somatostatin Most cited articles on Somatostatin | |
|
Media | |
|
Powerpoint slides on Somatostatin | |
|
Evidence Based Medicine | |
|
Clinical Trials | |
|
Ongoing Trials on Somatostatin at Clinical Trials.gov Clinical Trials on Somatostatin at Google
| |
|
Guidelines / Policies / Govt | |
|
US National Guidelines Clearinghouse on Somatostatin
| |
|
Books | |
|
News | |
|
Commentary | |
|
Definitions | |
|
Patient Resources / Community | |
|
Patient resources on Somatostatin Discussion groups on Somatostatin Patient Handouts on Somatostatin Directions to Hospitals Treating Somatostatin Risk calculators and risk factors for Somatostatin
| |
|
Healthcare Provider Resources | |
|
Causes & Risk Factors for Somatostatin | |
|
Continuing Medical Education (CME) | |
|
International | |
|
| |
|
Business | |
|
Experimental / Informatics | |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Phone:617-632-7753
Please Join in Editing This Page and Apply to be an Editor-In-Chief for this topic: There can be one or more than one Editor-In-Chief. You may also apply to be an Associate Editor-In-Chief of one of the subtopics below. Please mail us [2] to indicate your interest in serving either as an Editor-In-Chief of the entire topic or as an Associate Editor-In-Chief for a subtopic. Please be sure to attach your CV and or biographical sketch.
Somatostatin (also known as growth hormone inhibiting hormone (GHIH) or somatotropin release-inhibiting hormone (SRIF)) is a peptide hormone that regulates the endocrine system and affects neurotransmission and cell proliferation via interaction with G-protein-coupled somatostatin receptors and inhibition of the release of numerous secondary hormones.
Somatostatin has two active forms produced by alternative cleavage of a single preproprotein: one of 14 amino acids, the other of 28 amino acids.[1]
Production
Digestive system
Somatostatin is secreted in several locations in the digestive system:
- stomach
- intestine
- delta cells of the pancreas[2]
Brain
Somatostatin is produced by neuroendocrine neurons of the periventricular nucleus of the hypothalamus. These neurons project to the median eminence, where somatostatin is released from neurosecretory nerve endings into the hypothalamo-hypophysial portal circulation. These blood vessels carry somatostatin to the anterior pituitary gland, where somatostatin inhibits the secretion of growth hormone from somatotrope cells. The somatostatin neurons in the periventricular nucleus mediate negative feedback effects of growth hormone on its own release; the somatostatin neurons respond to high circulating concentrations of growth hormone and somatomedins by increasing the release of somatostatin, so reducing the rate of secretion of growth hormone.
Somatostatin is also produced by several other populations that project centrally - i.e. to other areas of the brain, and somatostatin receptors are expressed at many different sites in the brain. In particular, there are populations of somatostatin neurons in the arcuate nucleus, the hippocampus and the brainstem nucleus of the solitary tract.
Actions
Somatostatin is classified as an inhibitory hormone,[1] whose actions are spread to different parts of the body:
Anterior pituitary
In the anterior pituitary gland, the effects of somatostatin are:
- Inhibit the release of growth hormone (GH) [3] (thus opposing the effects of Growth Hormone-Releasing Hormone (GHRH))
- Inhibit the release of thyroid-stimulating hormone (TSH)
Gastrointestinal system
- Suppress the release of gastrointestinal hormones
- Lowers the rate of gastric emptying, and reduces smooth muscle contractions and blood flow within the intestine[3]
- Suppress the release of pancreatic hormones
- Suppress the exocrine secretory action of pancreas.
Synthetic substitutes
Octreotide (brand name Sandostatin, Novartis Pharmaceuticals) is an octopeptide that mimics natural somatostatin pharmacologically, though is a more potent inhibitor of growth hormone, glucagon, and insulin than the natural hormone.
References
- ↑ 1.0 1.1 Physiology at MCG 5/5ch4/s5ch4_16
- ↑ Costanzo, LS. Board Review Series: Physiology 3rd Ed. Lippincott, Williams & Wilkins. 2003. p. 280.
- ↑ 3.0 3.1 http://www.vivo.colostate.edu/hbooks/pathphys/endocrine/otherendo/somatostatin.html Colorado State University - Biomedical Hypertextbooks - Somatostatin
- ↑ 4.0 4.1 Physiology at MCG 5/5ch4/s5ch4_17
Digestive system, physiology: gastrointestinal physiology | |
|---|---|
| Enteric nervous system | Meissner's plexus - Auerbach's plexus |
| Exocrine | Chief cells (Pepsinogen) - Parietal cells (Gastric acid, Intrinsic factor) - Goblet cells (Mucus) |
| Endocrine/paracrine | G cells (gastrin), D cells (somatostatin) - ECL cells (Histamine) - enterogastrone: I cells (CCK), K cells (GIP), S cells (secretin) |
| Border | Brunner's glands - Paneth cells - Enterocytes |
| Fluids | Saliva - Bile - Intestinal juice - Gastric juice - Pancreatic juice |
| Processes | Swallowing - Vomiting - Peristalsis (Interstitial cell of Cajal) - Migrating motor complex - Borborygmus - Gastrocolic reflex - Segmentation contractions - Defecation |
Peptides: neuropeptides | |
|---|---|
| Hypothalamic | Somatostatin - CRH - GnRH - GHRH - Orexins - TRH - POMC (ACTH, MSH, Lipotropin) |
| Gastrointestinal hormones | Cholecystokinin - Gastric inhibitory polypeptide - Gastrin - Motilin - Secretin - Vasoactive intestinal peptide |
| Other hormones | Vasopressin - Calcitonin - |
| Other | Angiotensin - Bombesin/Neuromedin B - Calcitonin gene-related peptide - Carnosine - Delta sleep-inducing peptide - FMRFamide - Galanin - Gastrin releasing peptide - Kinins (Bradykinin, Tachykinins ) - Neuromedin (B, N, U) - Neuropeptide Y - Neurophysins - Neurotensin - Opioid peptide - Pancreatic polypeptide - Pituitary adenylate cyclase activating peptide |
Pituitary and hypothalamic hormones and analogues (H01) | |
|---|---|
| Anterior pituitary | Adrenocorticotropic hormone (Corticotropin, Tetracosactide) - Thyrotropin - Somatropin/agonists (Somatrem, Mecasermin, Sermorelin) - other (Pegvisomant) |
| Posterior pituitary | Vasopressin (Desmopressin, Lypressin, Terlipressin, Ornipressin, Argipressin) - Oxytocin (Demoxytocin, Carbetocin) |
| Hypothalamic | gonadotropin-releasing hormones (Gonadorelin, Nafarelin, Histrelin) - antigrowth hormone (Somatostatin, Octreotide, Lanreotide) - anti-gonadotropin-releasing hormones (Ganirelix, Cetrorelix) |
bg:Соматостатин cs:Somatostatin da:Somatostatin de:Somatostatin dv:ސޯމަޓަސްޓެޓިންit:Somatostatina he:סומטוסטטין nl:Somatostatineno:Somatostatinsr:Соматостатин sv:Somatostatin
Acknowledgement and Attribution Regarding Sources of Content
Some of the initial content on this page may be incorporated in part from copyleft sources in the public domain including wikis such as Wikipedia and AskDrWiki. Drug information for patients came from the The National Library of Medicine. Infectious disease information may have come from the Centers for Disease Control (CDC). Differential Diagnoses are drawn from clinicians as well as an amalgamation of 3 sources: 1.The Disease Database; 2. Kahan, Scott, Smith, Ellen G. In A Page: Signs and Symptoms. Malden, Massachusetts: Blackwell Publishing, 2004:3; 3. Sailer, Christian, Wasner, Susanne. Differential Diagnosis Pocket. Hermosa Beach, CA: Borm Bruckmeir Publishing LLC, 2002:7 .

